Oramorph sr and Emphysema - a phase IV clinical study of FDA data

Summary:

Emphysema is reported as a side effect among people who take Oramorph sr (morphine sulfate), especially for people who are male, 50-59 old, also take Neurontin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Emphysema when taking Oramorph sr. It is created by eHealthMe based on reports of 2,797 people who have side effects when taking Oramorph sr from the FDA, and is updated regularly.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,897 Oramorph sr users. Check the latest studies of Oramorph sr.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,077 drugs and 1,096 conditions by eHealthMe. Check the latest studies of Emphysema.

On Jul, 14, 2026

2,797 people reported to have side effects when taking Oramorph sr.
Among them, 14 people (0.5%) have Emphysema.

Among these 14 people:

What is the gender of people who have Emphysema when taking Oramorph sr? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Emphysema when taking Oramorph sr? *

What are other drugs people take besides Oramorph sr? *

What are other side effects people have besides Emphysema? *

Infection: 10 people, 71.43%
Haematochezia (passage of stools containing blood): 9 people, 64.29%
Prostate Cancer Metastatic: 9 people, 64.29%
Insomnia (sleeplessness): 9 people, 64.29%
Erection Problems: 9 people, 64.29%
Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)): 9 people, 64.29%
Deformity (disfigurement): 9 people, 64.29%
Muscle Swelling: 9 people, 64.29%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 9 people, 64.29%
High Blood Pressure: 9 people, 64.29%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 9 people, 64.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 14.29%
Tumor Lysis Syndrome: 1 person, 7.14%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
Nausea And Vomiting: 1 person, 7.14%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 7.14%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 7.14%
Gastritis (inflammation of stomach): 1 person, 7.14%
Depression: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Oramorph sr and have Emphysema?

- Check whether Emphysema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oramorph sr:

Oramorph sr (2,897 reports)

Emphysema treatments and more:

Emphysema (29,685 reports)

Browse all side effects of Oramorph sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emphysema:

Emphysema (1,077 drugs)

Browse all the conditions that are associated with Emphysema:

Emphysema (1,096 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Oramorph sr) and Oramorph sr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.